| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $112.0M | -70.7% |
| R&D Expense | $288.0M | +12.3% |
| SG&A Expense | $104.0M | +43.9% |
| Operating Income | -$280.0M | -616.1% |
| Pre-tax Income | -$266.0M | -586.8% |
| Income Tax | $1.0M | -44.9% |
| Net Income | -$267.0M | -605.4% |
| EPS (Basic) | -$3.71 | -588.2% |
| EPS (Diluted) | -$3.71 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $206.0M | +39.3% |
| Current Assets | $1.07B | -15.4% |
| Total Assets | $1.34B | -15.5% |
| Current Liabilities | $193.0M | +16.2% |
| Stockholders' Equity | $657.0M | -21.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $438.0M | +271.0% |
| Capital Expenditures | $6.0M | -77.0% |
| Investing Cash Flow | -$413.0M | — |
| Financing Cash Flow | $33.0M | -86.1% |
| Free Cash Flow | $432.0M | +253.1% |
| -622.5% |